Alegre, Brazil

Pedro A S Prado-Lima

This inventor holds 1 USPTO granted patent. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pedro A S Prado-Lima. Retrieved from https://idiyas.com/inventor/pedro-a-s-prado-lima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pedro A S Prado-Lima: Innovator in Anticonvulsant Derivatives

Introduction

Pedro A S Prado-Lima is a notable inventor based in Alegre, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticonvulsant derivatives. His work focuses on innovative treatments for depression, showcasing his commitment to advancing medical science.

Latest Patents

Pedro A S Prado-Lima holds 1 patent for his invention titled "Anticonvulsant derivatives useful for the treatment of depression." This patent discloses anticonvulsant derivatives that can be utilized as monotherapy or in combination therapy for treating depression. His research has the potential to improve the quality of life for many individuals suffering from this condition.

Career Highlights

Pedro is currently associated with Ortho-McNeil Pharmaceutical Corporation, where he continues to work on groundbreaking pharmaceutical innovations. His expertise in the field has positioned him as a valuable asset to the company and the broader medical community.

Collaborations

Throughout his career, Pedro has collaborated with esteemed colleagues, including Carlos Plata-Salaman and Josue Bacaltchuk. These partnerships have fostered a collaborative environment that enhances the development of innovative treatments.

Conclusion

Pedro A S Prado-Lima's contributions to the field of anticonvulsant derivatives highlight his dedication to improving mental health treatments. His innovative work continues to pave the way for advancements in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…